Key result
Review highlights hypertension gene identification strategies including Mendelian syndromes, genome-wide scans, and pharmacogenetics.
Why the study?
Genetic and genomic aspects of hypertension require synthesis, including strategies for gene identification and pharmacogenetic approaches.
Answers are grounded in this paper and cite their sources.
This review highlights current strategies for identifying genes associated with hypertension and discusses the potential of pharmacogenetics and genetic testing in complex polygenic traits.
This brief review discusses genetic and genomic aspects of hypertension. A special emphasis is given to currently available strategies for gene identifications, including studies of rare Mendelian hypertension, candidate gene evaluation, genome-wide scans and approaches based on the comparative genome analysis. We also discuss the growing potential for pharmacogenetic approaches and address briefly the issue of genetic testing in complex polygenic traits.
No takes yet. Share an insight, caveat, or question.
Dominiczak et al. (2004) conducted a review in Hypertension. This review highlights strategies for gene identification in hypertension, including Mendelian syndromes, genome-wide scans, and the growing potential for pharmacogenetic approaches.
Synapse has enriched 10 related papers. Consider them for comparative context: